New cancer drug enters first human trials for advanced solid tumors

NCT ID NCT06507306

Summary

This early-stage study is testing a new cancer drug called KQB198 in adults with advanced solid tumors that have spread or cannot be surgically removed. Researchers want to find the safest dose of KQB198 when taken alone or combined with other cancer drugs, and see if it helps shrink tumors. The study will enroll about 100 participants who have specific genetic mutations in their cancer and have run out of curative treatment options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Bordeaux - Hopital Saint-Andre

    RECRUITING

    Bordeaux, Nouvelle-Aquitane, 33000, France

  • CHU de Nantes - Hopital Nord Laennec

    RECRUITING

    Nantes, Pays de la Loire Region, 44000, France

    Contact Email: •••••@•••••

  • Chi-Mei Hospital - Liouying Branch

    WITHDRAWN

    Liuying, Tainan City, 73657, Taiwan

  • Chonnam National University Hwasun Hospital

    WITHDRAWN

    Hwasun, Jeollanam-do, 58128, South Korea

  • Clinica Universidad de Navarra - Pamplona

    RECRUITING

    Pamplona, 31008, Spain

    Contact Email: •••••@•••••

  • David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center

    RECRUITING

    Long Island City, New York, 11101, United States

    Contact Email: •••••@•••••

  • Florida Cancer Specialists - Sarasota

    RECRUITING

    Sarasota, Florida, 34232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore

    RECRUITING

    Rome, Lazio, 00168, Italy

    Contact Email: •••••@•••••

  • Henry Ford Health System

    RECRUITING

    Detroit, Michigan, 48202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Quirónsalud Málaga

    RECRUITING

    Málaga, 29004, Spain

    Contact Email: •••••@•••••

  • Hospital Universitari Quiron Dexeus Barcelona

    RECRUITING

    Barcelona, Catalonia, 08028, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, 28034, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Vall d'Hebron

    RECRUITING

    Barcelona, Catalonia, 08035, Spain

    Contact Email: •••••@•••••

  • IUCT-Oncopole

    RECRUITING

    Toulouse, Occitaine, 31059, France

    Contact Email: •••••@•••••

  • Institut Paoli-Calmettes

    RECRUITING

    Marseille, Bouches-du-Rhône, 13009, France

    Contact Email: •••••@•••••

  • Institut de Cancerologie de l'Ouest - site St-Herblain

    RECRUITING

    Saint-Herblain, Loire-Atlantique, 44800, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

    RECRUITING

    Napoli, 80131, Italy

  • MD Anderson Cancer Center

    WITHDRAWN

    Houston, Texas, 77030, United States

  • National Cancer Center

    WITHDRAWN

    Goyang-si, Gyeonggi-do, 10408, South Korea

  • National Taiwan University Hospital

    WITHDRAWN

    Taipei, Taipei City, 100225, Taiwan

  • New Experimental Therapeutics (NEXT) Oncology Barcelona

    RECRUITING

    Barcelona, 08023, Spain

    Contact Email: •••••@•••••

  • New Experimental Therapeutics (NEXT) Oncology Madrid - Hospital Quironsalud Madrid

    RECRUITING

    Madrid, 28223, Spain

    Contact Email: •••••@•••••

  • New Experimental Therapeutics of San Antonio - NEXT Oncology

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Email: •••••@•••••

  • New Experimental Therapeutics of Virginia - NEXT Oncology

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona -

    RECRUITING

    Orlando, Florida, 32827, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sarah Cannon Research Institute at HealthONE

    RECRUITING

    Denver, Colorado, 80218, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sarah Cannon and HCA Research Institute

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Seoul St. Mary's Hospital, The Catholic University of Korea

    WITHDRAWN

    Seoul, 06591, South Korea

  • Severance Hospital, Yonsei University Health System

    WITHDRAWN

    Seoul, 03722, South Korea

  • South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos

    RECRUITING

    Barcelona, 08023, Spain

    Contact Email: •••••@•••••

  • South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC

    RECRUITING

    Madrid, 28040, Spain

    Contact Email: •••••@•••••

  • South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz

    RECRUITING

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taichung Veterans General Hospital

    WITHDRAWN

    Taichung, 40705, Taiwan

  • Taipei Veterans General Hospital

    WITHDRAWN

    Taipei, 11217, Taiwan

  • The Lindner Center for Research and Education at The Christ Hospital

    RECRUITING

    Cincinnati, Ohio, 45219, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.